Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

New England Journal of Medicine 2026

View at publisher
Authors: Matthew J. Frigault, Binod Dhakal, Andrzej J. Jakubowiak, Noopur Raje, Kamalika Banerjee, C. Jenny Mu, Kevin C. Hart, Sigal Shachar, Lawrence P. Andrews, Laurene S. Cheung, Faith M. Griffin, Alexandra R. Witter
+15 more Michael Hyde, Chester Pham, Nikitha Gandra, Tenzin Shakya, Bhargavi Rajan, Christa Cortesio, Samuel T. Haile, Heba Nowyhed, Priyanka Nair-Gupta, Priyam Mitra, Rebecca J. Chan, Ana Kostic, Christopher R. Heery, Jacalyn Rosenblatt, Michael R. Bishop
DOI: 10.1056/nejmoa2603527
Cited by: 1
References: 21

Fields of Study & Subjects

CAR-T cell therapy research Cutaneous lymphoproliferative disorders research Immune Cell Function and Interaction

Publication details

Journal / source
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Volume
395
Issue
12
Pages
1180–1192
Publication date
23 September 2026
Language
EN